Clinical Trial: Clinical Trial to Slow the Progression of ADPKD

This study is not yet open for patient recruitment.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.

Condition Treatment or Intervention
Kidney, Polycystic
Kidney, Polycystic, Autosomal Dominant
 Drug: anti-hypertensive medications

MedlinePlus related topics:  Kidney Diseases
Genetics Home Reference related topics:  polycystic kidney disease

Study Type: Interventional
Study Design: Treatment, Active Control


Ages Eligible for Study:  15 Years   -   65 Years,  Genders Eligible for Study:  Both


Location Information

      University of Colorado Health Sciences Center, Denver,  Colorado,  80262,  United States
Lyn Tison  877-765-9297 

      Emory University, Atlanta,  Georgia,  United States

      Kansas University Medical Center, Kansas City,  Kansas,  United States

      Tufts - New England Medical Center, Boston,  Massachusetts,  United States

      Beth Israel Deaconess Medical Center, Boston,  Massachusetts,  United States

      Mayo Clinic, Rochester,  Minnesota,  United States

      Cleveland Clinic Foundation, Cleveland,  Ohio,  United States
 800-223-2273  Ext. 44680 

More Information

Study ID Numbers:  ADPKD
Record last reviewed:  November 2004
Last Updated:  November 17, 2004
Record first received:  September 3, 2003 Identifier:  NCT00067977
Health Authority: United States: Federal Government processed this record on 2005-04-08

Cache Date: April 9, 2005